DaVita Inc. (DVA) SEC filings

DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3041% below fair value

$174.07−9.43 (-5.14%)

Close on Nov 12, 2026Market cap $10.95BP/E 12.8Yield –

SEC filings

40 of DaVita's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Oct 29, 2026	SEC EDGAR
Current report	8-K	Oct 29, 2026	Oct 29, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 4, 2026	SEC EDGAR
Current report	8-K	Aug 4, 2026	Aug 4, 2026	SEC EDGAR
Current report	8-K	Jun 4, 2026	Jun 8, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 5, 2026	SEC EDGAR
Current report	8-K	May 5, 2026	May 5, 2026	SEC EDGAR
Proxy statement	DEF 14A	Dec 31, 2025	Apr 22, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 11, 2026	SEC EDGAR
Current report	8-K	Feb 2, 2026	Feb 2, 2026	SEC EDGAR
Current report	8-K	Nov 24, 2025	Nov 25, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Oct 29, 2025	SEC EDGAR
Current report	8-K	Oct 29, 2025	Oct 29, 2025	SEC EDGAR
Current report	8-K	Aug 20, 2025	Aug 20, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Aug 5, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Jul 17, 2025	Jul 17, 2025	SEC EDGAR
Current report	8-K	Jun 5, 2025	Jun 9, 2025	SEC EDGAR
Current report	8-K	May 23, 2025	May 23, 2025	SEC EDGAR
Current report	8-K	May 20, 2025	May 20, 2025	SEC EDGAR
Current report	8-K	May 20, 2025	May 20, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 12, 2025	SEC EDGAR
Current report	8-K	May 12, 2025	May 12, 2025	SEC EDGAR
Proxy statement	DEF 14A	Jun 5, 2025	Apr 24, 2025	SEC EDGAR
Current report	8-K	Apr 12, 2025	Apr 14, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Feb 13, 2025	SEC EDGAR
Current report	8-K	Feb 13, 2025	Feb 13, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Oct 29, 2024	SEC EDGAR
Current report	8-K	Oct 29, 2024	Oct 29, 2024	SEC EDGAR
Current report	8-K	Sep 9, 2024	Sep 13, 2024	SEC EDGAR
Current report	8-K	Sep 5, 2024	Sep 5, 2024	SEC EDGAR
Current report	8-K	Aug 13, 2024	Aug 14, 2024	SEC EDGAR
Current report	8-K	Aug 8, 2024	Aug 9, 2024	SEC EDGAR
Current report	8-K	Aug 8, 2024	Aug 8, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 6, 2024	SEC EDGAR
Current report	8-K	Aug 6, 2024	Aug 6, 2024	SEC EDGAR
Current report	8-K	Jun 6, 2024	Jun 10, 2024	SEC EDGAR
Current report	8-K	May 9, 2024	May 13, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 2, 2024	SEC EDGAR
Current report	8-K	May 2, 2024	May 2, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in DaVita's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Sep 9, 2013
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is DVA.

Compare: DVA vs AGL · DVA vs BTSG · DVA vs THC · DVA vs CYH · DVA vs LH

Revenue growth6.4% · median 6.0%

Operating margin15.0% · median 10.3%

Net margin6.5% · median 1.5%

Company	Revenue	Growth
THC	$22.15B	+6.2%
BTSG	$15.25B	+26.0%
LH	$14.59B	+6.0%
DVA	$14.17B	+6.4%
CYH	$11.65B	-7.8%
AGL	$6.00B	+2.0%

Company

Next earnings (est.): Feb 1, 2027, during market hours
Exchange: NYSE
Industry: Services-Misc Health & Allied Services, NEC
Fiscal year ends: December 31
Employees: 78,000
Held by institutions: 93.9%
Auditor: KPMG LLP
SEC CIK: 927066

Advertisement
300 × 250

See a number that looks wrong?